Abstract
Keywords
ACE Inhibitors (317)Adverse Drug Events (321)Angiotensin II Receptor Blockers (317)Aprepitant (323)Aspirin (319)Atazanavir (312)Cefepime (322)Cilostazol* (318)Ginkgo Biloba (313)Mesalazine (311)Mesoridazine (324)Midazolam (323)Minocycline (314)Moxifloxacin (310)Pegfilgrastim (316)Rifampicin (310)Risperidone (313)Thioridazine (324)Tramadol (320)Venlafaxine* (315)Warfarin (319)
Get full access to this article
View all access options for this article.